x

Search for a clinical trial

* (*) mandatory field

An early-phase, multicenter, open-label study of the safety and pharmacokinetics of Anti-PD-L1 Antibody (MPDL3280A) in pediatric and young adult patients with previously treated solid tumors (Phase I-II) - ES

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : Yes
  • Status : Ongoing trial
  • Funded by an IRDiRC member
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Hoffmann - la roche ltd.
    • Phase : I - II
  • Principal investigator of clinical trial

  • Dr Jaume MORA GRAUPERA
  • Servicio de Oncología y Hematología
  • Hospital Sant Joan de Déu Barcelona
  • Paseo de Sant Joan de Déu, 2
  • 08950 ESPLUGUES DE LLOBREGAT
  • SPAIN
  • More information
  • Phone  : 34 93 253 21 00
  • Fax  : -
  • Website
  • Investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Servicio de Oncohematología
  • Hospital Infantil Universitario Niño Jesús
  • Avenida Menendez y Pelayo, 65
  • 28009 MADRID
  • SPAIN
  • More information
  • Phone  : 34 915 035 900 ext. 565
  • Fax  : -
  • Website
  • Contact secretary  :
Last update: May 2019

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.